Staphylococcus lugdunensis Pulmonary Valve Endocarditis in a Patient on Chronic Hemodialysis
Authors:
- Sailaja KamarajuSKSailaja Kamaraju
- Karin NelsonKNKarin Nelson
- David N. WilliamsDWDavid N. Williams
- Kulwant Singh ModiKMKulwant Singh Modi
- 1 October 1999
- journal article
- case report
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 19 (5) , 605-608
Abstract
We describe a case of Staphylococcus lugdunensis pulmonary valve endocarditis in a 65-year-old woman on chronic hemodialysis and provide a review of previously reported cases. The patient presented with fever and altered mental status, but had no other localizing symptoms or signs; coagulase-negative staphylococcus (subsequently identified as S. lugdunensis) was isolated from two sets of blood cultures. Transthoracic and transesophageal echocardiograms showed a large (2.3 × 3.1 cm) vegetation on the pulmonary valve with moderate valvular insufficiency. The patient was treated with 6 weeks of antibiotic therapy and is stable 4 months following the completion of therapy; no surgical intervention was performed. Of the 28 previously reported cases of S. lugdunensis endocarditis, only 1 had previously survived with medical therapy alone. This is the 3rd case report of S. lugdunensis endocarditis in a patient on hemodialysis; the presumed portal of entry in this and previously reported cases was the vascular access device. Endocarditis due to this organism is characterized by a high mortality, rapid tissue destruction, and a predilection for native valves. Because the clinical outcome is much more favorable with valvular replacement, speciation of the organism assumes great importance in defining the therapeutic approach.Keywords
This publication has 1 reference indexed in Scilit: